PM
ALDR

Parametrica Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Parametrica Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,360
Closed -$309K – 136
2015
Q4 		$309K Buy
+9,360
New +$317K 2.03% 17

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Parametrica Management's ALDR Position: Q1 2016 in Review

Parametrica Management sold out of Alder Biopharmaceuticals (ALDR) in Q1 2016, closing a stake of 9,360 shares — an estimated $309K sold.

Parametrica Management first reported a position in ALDR in Q4 2015 and held it in 1 quarter. The position peaked at $309K in Q4 2015. 117 funds tracked by Wall St. Rank hold ALDR as of Q1 2016.

  • Parametrica Management reported no remaining Alder Biopharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Parametrica Management sold 9,360 Alder Biopharmaceuticals shares in Q1 2016, an estimated $309K.
  • Parametrica Management first reported a position in Alder Biopharmaceuticals in Q4 2015 and held it in 1 quarter.
  • Parametrica Management's Alder Biopharmaceuticals position peaked at $309K in Q4 2015.
  • 117 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2016.

Based on Parametrica Management's 13F filing for Q1 2016, filed 5 May 2016.